Prostasomes are exosomes such as extracellular vesicles, produced in the prostatic epithelium and released into the seminal plasma, that play an important role enhancing male fertility. Although some studies have demonstrated that prostasomes have a rich proteomic content, it is still unclear if that proteomic content varies depending on the male fertility status. Prostasomes from 12 normozoospermic and 14 non-normozoospermic seminal samples were isolated by differential ultracentrifugation. Protein content was studied by quantitative mass spectrometry and compared between both cohorts. We identified 1282 proteins with 745 of them (57.8%) being present in all seven prostasome pools. Forty-seven of those commonly present proteins showed differential expression levels in both cohorts. Specifically, prostasomes from non-normozoospermic samples showed a pattern of protein underexpression for a group of proteins including several proteins from the spermatozoa's energy production pathways as well as some proteins directly implicated in sperm activity. Variations in prostasomal protein content levels may have a relevant correlation with male fertility and thus could be of great utility as a biomarker of fertility status.
INTRODUCTION
Prostasomes are exosomes such as extracellular vesicles found in the seminal plasma in high concentrations. They are produced in the prostatic epithelium via the multivesicular body pathway and released into the seminal plasma via exocytosis during ejaculation (Aalberts et al., 2014) . Moreover, it is known that prostasomes fuse with the spermatozoa in the female reproductive tract although it is still not clear exactly where. Some studies point to an early fusion in the uterus, while others say that prostasomes in the uterus only bind to the spermatozoa surface, with the fusion taking place in the acidic environment of the Fallopian tubes when the spermatozoa are nearby the oocyte .
It has been demonstrated that prostasomes have important effects over fertility (Ronquist & Nilsson, 2004; Burden et al., 2006; Ronquist, 2015; Sullivan, 2015) . (i) They participate in the liquefaction process thanks to their content on prostatespecific antigen (PSA). (ii) They promote sperm motility as they transfer to the spermatozoa both their own calcium content as well as membrane calcium channels (mainly annexins). (iii) They regulate capacitation and acrosomal reaction in different ways: they transfer cholesterol and sphingomyelin to the sperm membrane preventing an early acrosomal reaction, but they also transfer several enzymes making the spermatozoa more sensitive to the effect of the progesterone released by the cumulus cells which is a potent stimulator of the acrosomal reaction. (iv) They have an antioxidant role as they reduce superoxide anion production by leukocytes. (v) They have antimicrobial properties as they contain peptides from the cathelicidin family. (vi) They have coagulant properties thus preventing sperm contact with female blood. (vii) They have immunosuppressive properties showing an effective inhibition of lymphocytes, macrophages, KN cells, and the complement system.
Several studies have been carried out to elucidate the content of human prostasomes. It has been demonstrated that they contain lipids (Jansen et al., 2013) , proteins (Utleg et al., 2003) , RNA (Vojtech et al., 2014) , and DNA (Ronquist et al., 2009) and that their main specific markers are prostatic acid phosphatase (PAP), prostate-specific antigen (PSA), transmembrane protease serine type 2 (TMPRSS2), aminopeptidase (CD13), prostate-specific transglutaminase (PST), and prostate stem cell antigen (PSCA). Regarding the prostasomal protein content, some studies have shown that they have a rich protein content which includes enzymes, transport and structural proteins, GTP proteins, chaperones, signal transduction proteins, and others (Utleg et al., 2003; Poliakov et al., 2009) . However, little is known about the differences in protein content of prostasomes from the seminal plasma of normozoospermic vs. non-normozoospermic men.
The aim of our study was to determine whether there exist representative differences in the prostasomal proteomic content between normozoospermic and non-normozoospermic men.
MATERIALS AND METHODS

Samples
The study was approved by the Bioethics Committee of the Universidad Aut onoma de Madrid (CEI 60-1058) . For this study, we used 26 human seminal samples: 12 samples diagnosed with normozoospermia and 14 diagnosed with non-normozoospermia according to the WHO 2010 standards. All samples were donated by different healthy men who did not have any other relevant pathology with known effect over fertility. All individuals included in the study obtained the samples by masturbation after 4 days of abstinence (regular abstinence period in the collaborating clinic), and the sperm quality diagnoses were made by qualified personnel from the collaborating clinic according to the WHO 2010 protocols. Additionally, eight samples obtained from eight additional healthy individuals, four of them with a diagnosis of normozoospermia and four with a diagnosis of nonnormozoospermia, were used for validation of proteomics data by Western blot.
Prostasome isolation
Prostasomes from all samples were isolated independently by differential ultracentrifugation. After liquefaction, spermatozoa and other cells were removed from the seminal samples by centrifugation at 500 g for 10 min, and an aliquot of each sample was then checked under microscope to confirm that no spermatozoa remained. The spermatozoa free seminal plasmas were stored at À20°C prior to isolation of prostasomes. After thawing, another centrifugation at 3000 g for 20 min was made to remove any other contamination. To remove any possible apoptotic bodies and large cell debris, the supernatants were then spun at 12,000 g for 20 min. Finally, exosomes were collected by spinning at 100,000 g for 70 min. Exosomes were washed in 20 mL PBS 19 and pelleted again by ultracentrifugation at 100,000 g for 70 min (Beckman 70Ti rotor).
All final prostasomal pellets were resuspended separately in 200 lL PBS1X.
Morphological characterization
Protein quantification
The protein quantity of all 26 pellets was determined using the BCA kit (BCA Protein Assay Kit, Cat No 23225, Thermo Scientific, Waltham, MA, USA) following the manufacturer's guidelines.
Size and particle analysis
Morphological parameters of all prostasomal pellets (particle concentration and diameter) were determined by nanoparticle tracking analysis (NTA) using the NanoSight System (NanoSight, Malvern Instruments, Salisbury, UK) equipped with a blue laser (405 nm). Briefly, prostasomal pools were diluted in PBS to a final dilution of 1 : 1000, and each pool analysis was conducted for 60 sec and measured three times.
Transmission electronic microscope
Four prostasomal pellets, two from normozoospermic samples and two from non-normozoospermic samples, were selected for a TEM study.
Proteomic study
Protein pools
Nine prostasomal pools were prepared to get a protein concentration of 100 lg/pool. For each pool, we mixed aliquots from two or four prostasomal samples with equal diagnosis so that each sample provided, respectively, 50 or 25 lg of protein to the pool. Four of those pools were prepared with prostasomes isolated from normozoospermic samples, while five were prepared with prostasomes isolated from non-normozoospermic samples. Three and four pools, respectively, were used for a massive study of the prostasomal protein content by mass spectrometry, while the two remaining pools where used for results validation with Western blot (see Table S1 ).
In gel digestion
The protein pools (100 lg/pool) were suspended in a volume up to 50 lL of sample buffer and then applied onto 1.2-cm-wide wells of a conventional SDS-PAGE gel (0.75 mm thick, 4% stacking, and 10% resolving). Then, run was stopped as soon as the front entered 3 mm into the resolving gel, so that the whole proteome became concentrated in the stacking/resolving gel interface. The unseparated protein bands were visualized by Coomassie staining, excised, cut into cubes (2 9 2 mm), and placed in 0.5-mL microcentrifuge tubes. The gel pieces were destained in acetonitrile:water (ACN:H 2 O, 1 : 1), were reduced and alkylated (disulfide bonds from cysteinyl residues were reduced with 10 mM DTT for 1 h at 56°C, and then thiol groups were alkylated with 50 mM iodoacetamide for 1 h at room temperature in darkness), and digested in situ with sequencing grade trypsin (Promega, Madison, WI, USA) as described by Shevchenko et al. (Shevchenko et al., 1996) with minor modifications. The gel pieces were shrunk by removing all liquid using sufficient ACN. Acetonitrile was pipetted out, and the gel pieces were dried in a speedvac. The dried gel pieces were reswollen in 50 mM ammonium bicarbonate pH 8.8 with 60 ng/lL trypsin at 5 : 1 protein:trypsin (w/w) ratio. The tubes were kept in ice for 2 h and incubated at 37°C for 12 h. Digestion was stopped by the addition of 1% TFA. Whole supernatants were dried down and then desalted onto OMIX Pipette tips C18 (Agilent Technologies, Madrid, Spain) until the mass spectrometric analysis.
Reverse-phase liquid chromatography RP-LC-MS/MS analysis (dynamic exclusion mode)
The desalted protein digest (2 lg) was dried, resuspended in 10 ll of 0.1% formic acid, and analyzed by RP-LC-MS/MS in an Easy-nLC II system coupled to an ion trap LTQ-Orbitrap Velos Pro hybrid mass spectrometer (Thermo Scientific). The peptides were concentrated (online) by reverse-phase chromatography using a 0.1 mm 9 20 mm C18 RP precolumn (Thermo Scientific) and then separated using a 0.075 mm x 250 mm C18 RP column (Thermo Scientific) operating at 0.3 lL/min. Peptides were eluted using a 180-min dual gradient from 5 to 25% solvent B in 120 min followed by gradient from 25 to 40% solvent B over 180 min (Solvent A: 0.1% formic acid in water; solvent B: 0.1% formic acid, 80% acetonitrile in water). ESI ionization was carried out using a Nano-bore emitters Stainless Steel ID 30 lm (Proxeon) interface. The Orbitrap resolution was set at 30.000.
Peptides were detected in survey scans from 400 to 1600 amu (1 lscan), followed by fifteen data-dependent MS/MS scans (Top 15), using an isolation width of 2 u (in mass-to-charge ratio units), normalized collision energy of 35%, and dynamic exclusion applied during 30 sec periods.
iTRAQ labeling
The resultant peptide mixture from proteins tryptic digest was labeled using chemicals from the iTRAQ reagent 8plex Multiplex kit (reagents 113, 114, 115, 116, 117, 118, 119 , and 121) (Applied Biosystems). Briefly, peptides were dissolved in 0.5 M triethylammonium bicarbonate (TEAB), adjusted to pH 8. For labeling, each iTRAQ reagent was dissolved in 50 lL of isopropanol and added to the respective peptide mixture and then incubated at room temperature for two hours. Labeling was stopped by the addition of 0.1% formic acid. Whole supernatants were dried down, and the eight samples were mixed to obtain the '8plex-labeled mixture'. The mixture was desalted onto OASIS HLB Extraction Cartridges (Waters Corporation) until the mass spectrometric analysis.
The desalted 8plex-labeled mixture was dried, resuspended in 10 lL of 0.1% formic acid, and analyzed by RP-LC-MS/MS in an Easy-nLC II system coupled to an ion trap LTQ-Orbitrap Velos Pro hybrid mass spectrometer (Thermo Scientific). The peptides were concentrated (online) by reverse-phase chromatography using a 0.1 mm 9 20 mm C18 RP precolumn (Proxeon) and then separated using a 0.075 mm 9 250 mm C18 RP column (Proxeon) operating at 0.3 lL/min. Peptides were eluted using a 240-min dual gradient from 5 to 25% solvent B in 180 min followed by gradient from 25 to 40% solvent B over 240 min (Solvent A: 0,1% formic acid in water; solvent B: 0,1% formic acid, 80% acetonitrile in water). ESI ionization was carried out using a Nano-bore emitters Stainless Steel ID 30 lm (Proxeon) interface.
The instrument method consisted of a data-dependent top-20 experiment with an Orbitrap MS1 scan at a resolution (m/Dm) of 30,000 followed by either twenty high-energy collision dissociation (HCD) MS/MS mass-analyzed in the Orbitrap at 7500 (Dm/m) resolution. MS2 experiments were performed using HCD to generate high resolution and high mass accuracy MS2 spectra.
The minimum MS signal for triggering MS/MS was set to 500. The lock mass option was enabled for both MS and MS/MS mode, and the polydimethylcyclosiloxane ions (protonated (Si (CH3)2O))6; m/z 445.120025) were used for internal recalibration of the mass spectra.
Peptides were detected in survey scans from 400 to 1600 amu (1 lscan) using an isolation width of 2 u (in mass-to-charge ratio units), normalized collision energy of 40% for HCD fragmentation, and dynamic exclusion applied during 30 sec periods. Precursors of unknown or +1 charge state were rejected.
Data analysis
Peptide identification from raw data was carried out using the SEQUEST algorithm (Proteome Discoverer 1.4, Thermo Scientific). Database search was performed against uniprot-Homo.-fasta. The following constraints were used for the searches: tryptic cleavage after Arg and Lys, up to two missed cleavage sites, and tolerances of 10 ppm for precursor ions and 0.05 Da for MS/MS fragment ions and the searches were performed allowing optional Met oxidation, Cys carbamidomethylation, and iTRAQ reagent labeling at the N-terminus and lysine residues. Search against decoy database (integrated decoy approach) using false discovery rate (FDR) < 0.01. All proteins are identified with at least two peptides with high confidence.
Quantitation of iTRAQ-labeled peptides was performed with Proteome Discoverer 1.4 using a Workflow for processing raw files with HCD spectra for quantification (and identification). The Reporter Ions Quantifier node contains a specific quantification method for iTRAQ 8plex (in Thermo Scientific Instruments). For the ratio calculations, we use Quan Value corrections, and for the Protein quantification, we consider protein groups for peptide uniqueness and use only unique peptides. Tolerances of 10 ppm for peak integration and most confident centroid for integration method were selected. Relative protein abundance changes were determined using the PEAKS 8 software with the PEAKS Q package for statistical analysis (Cox & Mann, 2008) .
The identified proteins were classified according to their Go Ontology categories (Panther Classification System). Comparisons between groups were made with the program FUNRICH (Functional Enrichment Analysis Tool) (Pathan et al., 2015) , and protein interactions were determined with the STRING Database (Szklarczyk et al., 2015) .
Proteomic results validation
Proteomic quantitative results were validated by Western blot for two selected proteins: lactate dehydrogenase C (LDHC) and hexokinase I (HK1). For each of them, four prostasomal pools were used, two from normozoospermic samples and two from non-normozoospermic samples. From those pools, two, one for each type, were prepared by mixing equal quantities of each of the pools used in the mass spectrometry study, while the remaining polls were new pools for validation. All pools were diluted to a final protein concentration of 3 lg/pool. 10 lL of each pool were mixed with 2.5 lL of homemade RIPA buffer enriched with protease inhibitors (cOmplete TM Protease Inhibitor Cocktail, Cat No 000000011697498001, Roche Diagnostics, Mannheim, Germany) and subjected to 3 min of maximum potency sonication (Bioruptor Sonication System UCD-200, Diagenode, Liege, Belgium) and 15 min of ice incubation for protein extraction. Regular denaturing acrylamide gels were prepared (10% for LDHC and 8% for HK1) in which we run 10 lL extracted sample per well during 2 h at 120V. Afterward, we transferred the separated proteins to a nitrocellulose membrane (Amersham Hybond-P PVDF membrane, Cat No RPN303F, GE Healthcare Life Sciences, Buckinghamshire, UK) and labeled both proteins. 
RESULTS
It was possible to isolate the prostasomal content of all samples obtaining in all cases good pellets which could clearly be seen in the ultracentrifuge tubes. We obtained a media of particle concentration of 1.30E+13/mL and a media of diameter of 146 nm.
TEM analysis showed a similar morphological pattern in all four prostasomal samples (see Fig. 1 ). In all cases, we could differentiate two prostasomal subpopulations: one bigger with high electron density and another smaller with low electron density.
For the morphological parameters, we observed that the normozoospermic isolates have slightly less particle concentrations as well as particle diameter than the non-normozoospermic ones (2.47E+12/mL vs. 4.02E+12/mL and 143 nm vs. 148 nm, respectively). However, those differences were not statistically significant. As expected, we found a positive almost significant correlation between particle and protein concentration in our samples (Spearman's Rho = 0.337, p = 0.051).
In the proteomic analysis, 1282 different proteins were detected in the whole of the seven pools being 745 of them (57.8%) present in all pools. Those common proteins fulfilled almost all the ISEV requirements for exosome proteomic characterization (L€ otvall et al., 2014) (see Table S1 ). Specifically, they included four proteins considered as specific prostasomal markers (prostatic acid phosphatase (PAP), prostate-specific antigen (PSA), transmembrane protease serine type 2 (TMPRSS2), and aminopeptidase (CD13)) but did not include cell markers such us calnexin (CANX) or cytochrome C (CYC), indicating that our prostasomal isolates are not contaminated with cell debris.
Those common proteins were classified according to their GO Ontology annotations (see Fig. 2 ):
• Molecular function: 52.1% were proteins with catalytic activity, while 28.7% were binding proteins.
• Biological process: About a quarter of the proteins were proteins which participate in cellular processes, and another quarter were proteins which participate in metabolic processes. Less than 1% were proteins related to reproductive processes.
• Cellular component: 43% were structural proteins, 25% are organelle components, and 12% are membrane proteins. Among the detected proteins only nine proteins where proteins related to reproductive processes according to the GO Ontology annotations (see Table 1 ):
Comparison of those proteins present in all prostasome pools with previously published data from other studies (Utleg et al., Poliakov et al., Ronquist et al., 2013b) and Yang et al., 2017) showed that there were 53 proteins which had been identified in all studies. Also, when comparing our results only with the studies by Ronquist et al. and Yang et al., which are the most similar to ours both in year of realization and in number of samples included, we observed that they shared 366 proteins which means that almost half of the proteins that they had identified also appeared in all of our samples (see Fig. 3 ).
Also, when comparing with other studies in terms of percentage of the main types of proteins, we observed important similitudes with both the studies by Poliakov et al. and Ronquist et al. (see Fig. 4 ).
When comparing normozoospermic with non-normozoospermic samples, we identified five proteins which appeared exclusively in one of the two cohorts: two proteins which appeared in all normozoospermic pools but in none of the non-normozoospermic pools (Ras-related protein Rab-22A and 26S protease regulatory subunit 10B) and three proteins which appeared in all non-normozoospermic pools but not in the normozoospermic ones (charged multivesicular body protein 2b, exportin-1, and 40S ribosomal protein S19) (see Table 2 ).
Prostasomes from both normozoospermic and non-normozoospermic samples showed similar percentages of proteins for the main Go Ontology categories of molecular function and biological process (see Fig. 5 ). Interesting, when we compared both groups and searched for the Go Ontology categories of molecular function and biological process which showed the biggest change in percentage of proteins, we observed an increase in the percentage of proteins related to motility and cell adhesion in the normozoospermic prostasomes (see Fig. 6 ). Finally, when we studied those proteins which were identified in all samples and compared expression levels between normozoospermic and non-normozoospermic groups, we observed a clear pattern of protein overexpression in prostasomes from normozoospermic samples (see Fig. 7 ). Specifically, we found 43 proteins which showed significant differences in expression levels (fold change <0.80 or fold change>1.20) between the two options: seven proteins which were significantly overexpressed in prostasomes from non-normozoospermic samples and 36 which were underexpressed (see Table 3 ).
When we searched for protein interactions between those proteins which were underexpressed in prostasomes from non-normozoospermic men, we found eight proteins which were related to the energy production pathways in the spermatozoa: GLUT 3, HK1, LDHC, APRT, AK1, PNP, and CMPK1.
As shown in Fig. 8 and Table 4 , differential protein expression results were validated by Western blot for proteins HK1 and LDHC.
DISCUSSION
Seminal plasma is rich in exosome such as extracellular vesicles produced by the prostate epithelium and thus called prostasomes. It has been demonstrated that prostasomes fuse with the spermatozoa increasing sperm motility and participating in sperm capacitation and acrosome reaction modulation. Furthermore, prostasomes provide other properties beneficial for fertility such us antioxidant, antibacterial, immunosuppression, or coagulant functions. Most of these properties are due to the protein cargo present in the prostasomes which is transferred to the spermatozoa and acts as a reservoir for protein reposition. In our study, we demonstrated that the prostasomal protein cargo differs between prostasomes from normozoospermic and non-normozoospermic men, especially in levels of expression.
When we analyzed the morphological aspects of the prostasomes isolated from our samples, we observed that two different types of prostasomes were present: one type bigger and with high electron density and another smaller with low electron density and less smooth surface. This observation is concordant with the observations of Poliakov et al. who also described two similar types of prostasomes in seminal plasma from three healthy volunteers. Moreover, when we compared prostasomes isolated from seminal plasma from normozoospermic men with those isolated from seminal plasma from non-normozoospermic men, we could not find significant differences in particle concentration or diameters although we observed a higher concentration of lipidic particles as well as multivesicular bodies in the isolates from normozoospermic men.
We could identify 1282 different proteins in our prostasomal pools being 745 of them expressed in all pools (57.8%). This number of identified proteins is higher than the number of proteins identified in other studies previously published by other groups (see Table 5 ). This difference may be explained based (i) on the evolution of the mass spectrometry systems whose sensitivity is continuously increasing (it is clear that the more recent the study the more proteins detected), (ii) on the number of samples included in the study, and (iii) on the purification method used after prostasome isolation by ultracentrifugation as, while the other studies used more specific purification methods such us sucrose gradients or cushions, we only performed an additional washing and ultracentrifugation step with PBS.
Regarding the number of common proteins, our study showed that prostasomal protein content is quite constant in terms of Figure 2 Graphical representation of the protein groups present in prostasomes according to their GO Ontology annotations. Ronquist et al. and Yang et al., we observed that almost half of the proteins that they had identified also appeared in all of our pools. Part of those differences may be due to intersample variations but part could also be due to only very abundant proteins being consistently identified across studies. Some controversy still exists among the scientific community regarding if exosomal cargo is specifically selected for each type of exosome or just a number of proteins placed into exosomes by chance. Our observations may serve to strengthen the first idea as it is very improbable to obtain such a high percentage of common proteins just by random sorting of proteins into prostasomes.
Most of the proteins that have been previously described in literature as proteins present in prostasomes were also identified in our study. This includes some proteins which are thought to be exclusively present in prostasomes such as dipeptidyl Figure 5 Comparison of the protein content of prostasomes isolated from normozoospermic seminal samples with the protein content of prostasomes isolated from non-normozoospermic seminal samples in terms of percentage of the main Go Ontology categories of molecular function and biological process.
peptidase II, III, and IV, neprilysin, phospholipase A1, aminopeptidase, and gamma-glutamyl-transpeptidase but also other proteins such as annexins (1, 2, 3, 4, 5, 6, 7, 13) , chaperons (Hsp70 and Hsp90), RAS family proteins (RAB, RAP, and ARF), 14-3-3 proteins (a, b, e, f, g, h, r, and c), and kallikreins. Interesting, in a previous study, Ronquist et al. had identified 30 proteins which were present in prostasomes from four different species (human, dog, horse, and bull) (Ronquist et al., 2013a) , and we could identify in our study all those proteins with the exception of the T-complex protein 1. Moreover, they identified in human prostasomes 21 glycolysis-associated proteins (enzymes involved in ATP metabolic turnover and hexose transporters) and found that 12 of them were also present in prostasomes from other species; in our study, we identified 18 of those proteins including the 12 ones that they had identified to be present in all four species.
When we compared the protein content of prostasomes isolated from normozoospermic seminal samples with the protein content of prostasomes isolated from non-normozoospermic seminal samples, we could only find five proteins which appeared exclusively in one of the two cohorts (0.04% of the identified proteins). Moreover, none of those five proteins were proteins implicated in reproductive processes. Also, both groups of samples showed similar percentages of proteins for the main Go Ontology categories of molecular function and biological process. Interesting, when we compared both groups and searched for the Go Ontology categories of molecular function and biological process which showed the biggest change in percentage of proteins, we observed an increase in the percentage of proteins related to motility and cell adhesion in the normozoospermic prostasomes. This may be an important observation Figure 6 Comparison of the protein content of prostasomes isolated from normozoospermic seminal samples with the protein content of prostasomes isolated from non-normozoospermic seminal samples in terms of change in percentage of the main Go Ontology categories of molecular function and biological process.
592 Andrology, 2018, 6, 585-596 
© 2018 American Society of Andrology and European Academy of Andrology
Andrology, 2018, 6, 585-596 593 PROSTASOME PROTEINS ARE POTENTIAL FERTILITY MARKERS as both motility and cell adhesion are principal capacities needed for an adequate sperm functionality.
On the contrast, when we selected the proteins which were identified in all seven pools and compared expression levels between normozoospermic and non-normozoospermic samples, we found 43 proteins which showed significant differences in expression between both cohorts. From those proteins, seven proteins were significantly overexpressed in prostasomes from non-normozoospermic samples, while 36 were underexpressed. Moreover, when studying the proteins which showed significant differences in levels of expression between normozoospermic and non-normozoospermic samples, we could identify several proteins with relevant roles in fertility. Between the proteins which were underexpressed in prostasomes from non-normozoospermic men, we could identify (i) proteins which are part of the spermatozoa energy production pathways; (ii) cysteine-rich secretory protein 1 (CRISP1), which is a protein participating in the spermatozoa-ZP binding protein recognition (Ashrafzadeh et al., 2013) ; and (iii) kallikrein 2 (KLK2), a protein which participates in semen liquefaction (da Silva et al., 2016) . On the contrary, we observed that histone H2B type 1-A (HIST1H2BA), a testis-specific histone variant with an essential role in sperm DNA organization and sperm histone-protamine transition (Li et al., 2005; Montellier et al., 2013) , was overexpressed in prostasomes from non-normozoospermic men. Interestingly, all those proteins had also been identified in prostasomes from healthy men in the study by Poliakov et al. and almost all in the study by Ronquist et al. Of great interest, between the proteins which were underexpressed in prostasomes from non-normozoospermic men, we identified seven proteins which are part of the spermatozoa energy production pathways: GLUT 3, HK1, LDHC, APRT, AK1, PNP, and CMPK1. It is known that mammalian spermatozoa can switch between different metabolic pathways to get their energy requirements depending both on the oxygen and metabolic substrates availability (Storey, 2008; Dias et al., 2014) and that they preferentially use the glycolytic pathways instead of the oxidative phosphorylation via in order to minimize ROS production (Nascimento et al., 2008; du Plessis et al., 2015) . In addition, the glycolytic enzymes such as GLUT3 and HK1 have been localized in the sperm flagellum near the fibrous sheath where they Figure 8 Validation of differential protein expression results for proteins HK1 and LDHC. For both proteins, normozoospermic pools show higher concentrations than non-normozoospermic pools. 1: Mix of pools employed in mass spectrometry. 2. New independent pools not employed in mass spectrometry. produce part of the energy needed for sperm motility as mitochondria are only located in the midpiece. LHDC, an enzyme that catalyzes the reversible conversion of pyruvate to lactate with a concomitant production of NAD + needed for a rapid glycolysis, appears to have a key role in sperm capacitation thanks to the high concentration of pyruvate present in the female reproductive tract (Hereng et al., 2011) . Another enzyme that plays an important role in energy production and sperm motility in AK1; this enzyme, located in the flagellum, catalyzes the production of ATP using ADP as a substrate and thus provides an extra source of ATP needed to get slower and more fluid waves that propagate down the flagellum (Cao et al., 2006; Vadnais et al., 2014) . Consequently, a reduction on the quantity or quality of those proteins both in the spermatozoa itself or in the prostasomes reservoir may have an extremely detrimental effect over fertility as it may compromise the sperm energy production. According to our results, an important part of the prostasomal cargo is common independently of the quality of the sample as a consequence of an active selection of the prostasomal cargo. The observed differences in terms of type of proteins could be mostly due to small intersample variations without a relevant effect over fertility. In contrast, the differences in levels of expression of common proteins may have a biological significance and a relationship with the quality of the sample with non-normozoospermic samples showing patterns of protein subexpression. As it is known that prostasomes fuse with the spermatozoa primarily in the acidic ambient of the female reproductive tract (Arienti et al., 1999) and thus it is not feasible that they have had a direct relevant effect over spermatozoa in the seminal samples, we hypothesize that the observed differences in protein levels may be a reflexion in the prostate fluids of the status of the reproductive male system. Males with a healthy reproductive status would have both a normozoospermic seminal sample diagnosis and a prostasomal proteomic signature with a tendency to protein overexpression, while males with a reproductive system failure would have a non-normozoospermic seminal sample diagnosis and a prostasomal proteomic signature with a tendency to protein underexpression.
If we assume our hypothesis that the observed differences in protein levels in the prostasomal cargo may be a reflexion in the prostate fluids of the status of the reproductive male system, this would mean that there is a high chance that those same proteins are equally overexpressed or underexpressed in the corresponding spermatozoa itself. In fact, some of the proteins that we found to be differentially expressed in prostasomes from normozoospermic and non-normozoospermic men had already been found in a previous study by Legare et al. to be equally differentially expressed in spermatozoa from patients when compared with spermatozoa from fertile men: Histone H2B type 1 was overexpressed in spermatozoa from patients with IVF failure, while L-lactate dehydrogenase and epididymal sperm-binding protein 1 were underexpressed in spermatozoa from infertile patients (Legare et al., 2014) . Moreover, other proteins that we found to be differentially expressed in prostasomes from normozoospermic and non-normozoospermic men such as beta-microseminoprotein (MSMB) or macrophage migration inhibitory factor (MIF) had already been described to be differentially present in seminal plasma from normozoospermic and non-normozoospermic men. Consequently, our observations in the prostasomal proteomic cargo could have extremely relevant interpretations for fertility.
Moreover, this situation may have a second interpretation as this apparent equilibrium in quality between the spermatozoa and their surrounding seminal plasma prostasomal cargo implies that less quality spermatozoa samples will also be subjected to less quality prostasomal cargo when prostasome-spermatozoa fusion takes place in the female track thus not allowing a spermatozoa quality improvement via the prostasomal effect. Ronquist et al. also proposed that prostasomes produce high levels of ATP extracellularly which interact with receptors in the sperm surfaces and participate in the acrosome reaction; if so, an underexpression of ATP producing enzymes in prostasomes could have a detrimental effect over fertility.
Finally, it is also important to highlight that infertility has been previously proposed to be a precursor of male reproductive cancers (Walsh, 2011; Tvrda et al., 2015) . In concordance with that idea, we have observed that some of the proteins that we have found to be differentially expressed in prostasomes from normozoospermic and non-normozoospermic men have been described previously in the literature as prostate cancer diagnosis biomarkers (i.e. beta-microseminoprotein, glutamate carboxypeptidase 2, kallikreins, or prosaposin) (Koochekpour et al., 2005; Whitaker et al., 2010) . Thus, prostasomal protein content may have a relevant utility not only as a biomarker of fertility status but also as a biomarker for an early diagnosis of prostate diseases.
